GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Cash Flow for Lease Financing

Vilacto Bio (Vilacto Bio) Cash Flow for Lease Financing : $0.00 Mil (TTM As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Cash Flow for Lease Financing?

Vilacto Bio's Cash Flow for Lease Financing for the three months ended in Jun. 2019 was $0.00 Mil. Vilacto Bio's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Mar. 2019 ), Vilacto Bio's Cash Flow for Lease Financing remained the same in Jun. 2019 ($0.00 Mil).

Vilacto Bio Cash Flow for Lease Financing Historical Data

The historical data trend for Vilacto Bio's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Cash Flow for Lease Financing Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vilacto Bio Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vilacto Bio Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Cash Flow for Lease Financing
Comparable Companies
CAW SUMR HKSE:01259 XKRX:266870 XBUL:4L4 DHA:GOLDENSON XKLS:5022 CAI:COSG XKLS:7149 LSE:CRL MIL:FED IST:DENCM WAR:DEL TPE:1732 XBUL:6AR XKLS:0049 ASX:ZNO BOM:506522 ZAG:SAPN WAR:HRP
Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Website
https://www.vilacto.com
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.